KBC Group NV - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
KBC Group NV ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q4 2020$2,156,000
+509.0%
158,664
+35.7%
0.00%0.0%
Q3 2020$354,000
-37.0%
116,922
-39.5%
0.00%
-50.0%
Q2 2020$562,000
-11.1%
193,332
-13.7%
0.00%
-60.0%
Q1 2020$632,000
-1.7%
224,014
+13.0%
0.01%
+25.0%
Q4 2019$643,000
+50.2%
198,2330.0%0.00%
+33.3%
Q3 2019$428,000
-46.3%
198,233
-21.9%
0.00%
-50.0%
Q2 2019$797,000
+27.5%
253,780
+51.1%
0.01%
+20.0%
Q1 2019$625,000
+169.4%
167,954
+109.7%
0.01%
+66.7%
Q4 2018$232,000
-71.8%
80,092
-74.4%
0.00%
-50.0%
Q3 2018$823,000
-0.5%
312,744
-11.5%
0.01%
-14.3%
Q2 2018$827,000
-15.3%
353,450
+6.5%
0.01%
-22.2%
Q1 2018$976,000
+11.2%
331,950
+3.6%
0.01%
+12.5%
Q4 2017$878,000
+126.9%
320,456
+180.6%
0.01%
+100.0%
Q3 2017$387,000
+460.9%
114,184
+306.2%
0.00%
+300.0%
Q2 2017$69,000
-35.5%
28,113
-40.5%
0.00%0.0%
Q1 2017$107,000
-93.4%
47,275
-89.6%
0.00%
-96.7%
Q4 2015$1,616,000
-27.5%
456,616
+3.0%
0.03%
-33.3%
Q3 2015$2,230,000
-17.7%
443,387
+5.2%
0.04%
+28.6%
Q2 2015$2,710,000
-5.6%
421,343
+3.3%
0.04%
-5.4%
Q1 2015$2,870,000
-51.8%
408,059
-47.1%
0.04%
-47.9%
Q4 2014$5,950,000
+48.1%
771,661
+43.5%
0.07%
-49.3%
Q3 2014$4,018,000
-23.2%
537,850
-0.5%
0.14%
+133.3%
Q2 2014$5,234,000
+154.7%
540,743
+118.7%
0.06%
+87.5%
Q1 2014$2,055,000
+12.4%
247,273
+14.2%
0.03%
+14.3%
Q4 2013$1,828,000216,5760.03%
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
KESTREL INVESTMENT MANAGEMENT CORP 1,585,500$3,710,0001.36%
SMH CAPITAL ADVISORS INC 83,369$195,0000.32%
West Family Investments, Inc. 338,141$791,0000.20%
Matarin Capital Management, LLC 927,289$2,169,856,0000.16%
ROCKY MOUNTAIN ADVISERS, LLC 14,300$33,0000.12%
Alambic Investment Management, L.P. 163,200$382,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 1,760,376$4,119,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 5,677,647$13,286,0000.08%
Zebra Capital Management LLC 67,892$159,0000.07%
Fortis Advisors, LLC 45,602$107,0000.06%
View complete list of PDL BIOPHARMA INC shareholders